Department of Chemestry
Short biography and Publications by Carl-Wilhelm Vogel
Short biography
| 1951 | born in Hamburg |
| 1976 | Doctorate (Medicine) with Eberhard Königk in Hamburg (Bernhard Nocht Institute) |
| 1976-1978 | Medical Assistant (University of Hamburg, University of Kiel, Geesthacht District Hospital) |
| 1979-1982 | PostDoc at the Scripps Clinic and Research Foundation in La Jolla |
| 1982-1991 | Assistant/Associate/Full Professor Depts. of Biochemistry/Molecular Biology, Internal Medicine, and Lombardi Cancer Center, Georgetown University Washington |
| 1985 | Research Career Development Award, National Cancer Institute, USA |
| 1986 | Doctorate (biochemistry) with Günther Gercken in Hamburg |
| 1987 | Alan Berman Research Award Naval Research Laboratory Dept. of the Navy USA |
| 1990-1999 | Professor (C4) of Biochemistry in Hamburg |
| 1991 | Member of the American Society for Clinical Investigation |
| 1995 | Child Philipp Prize for leukemia research |
| 1997 | Fellow of the American Society for Clinical Pathology |
| 1997 | Life Fellow College of American Pathologists |
| 1999- | Professor, Cancer Research Center of Hawaii at the University of Hawaii |
| 1999-2008 | Director of the Cancer Research Center of Hawaii at the University of Hawaii |
Further Information
Publications
(only until the end of Hamburg time, until 1999)
.
| Search: Chemistry Dep. / all Hamburg | |
| 1999 | |
| 79 |
Effect of complement consumption by cobra venom factor on the course of primary infection with simian immunodeficiency virus in rhesus monkeys Jorn E. Schmitz, Michelle A. Lifton, Keith A. Reimann, David C. Montefiori, Ling Shen, Paul Racz, Klara Tenner-Racz, Markus W. Ollert , Meryl A. Forman, Rebecca S. Gelman, Carl-Wilhelm Vogel, Norman L. Letvin AIDS Research and Human Retroviruses 15, 195-202 (1999) |
| 78 |
A nonhuman primate model for the selective elimination of CD8+ lymphocytes using a mouse-human chimeric monoclonal antibody Jorn E. Schmitz, Meredith A. Simon, Marcelo J. Kuroda, Michelle A. Lifton, Markus W. Ollert , Carl-Wilhelm Vogel, Paul Racz, Klara Tenner-Racz, Bernard J. Scallon, Margaret Dalesandro, John Ghrayeb, E. Peter Rieber, Vito G. Sasseville, Keith A. Reimann American Journal of Pathology 154, 1923-1932 (1999) |
| 77 |
Human natural immunoglobulin M antibodies induce apoptosis of human neuroblastoma cells by binding to a Mr 260,000 antigen Kerstin A. David, Markus W. Ollert , Caren Vollmert, Sven Heiligtag, Britta Eickhoff, Rudolf Erttmann, Reinhard Bredehorst, Carl-Wilhelm Vogel Cancer Research 59, 3768-3775 (1999) |
| 76 |
Natural
human IgM-antibodies in neuroblastoma therapy: preliminary findings of a phase I/II clinical trial Caroline Schmitt, Kerstin A. David, J. Hiller, J. Schrum, Reinhard Bredehorst, Carl-Wilhelm Vogel, C. Löliger, Rudolf Erttmann Klinische Pädiatrie 211, 314-318 (1999) |
| 75 |
Serotype distribution and secretory acid proteinase activity of Candida albicans isolated from the oral mucosa of patients with denture stomatitis C. G. McMullan-Vogel, H. D. Jude, Markus W. Ollert , Carl-Wilhelm Vogel Oral Microbiology and Immunology 14, 183-189 (1999) |
| 74 |
Novel cobra venom factors and their use in lowering complement activity via recombinant proCVF Carl-Wilhelm Vogel, Reinhard Bredehorst, David C. Fritzinger, Michael A. Kock Patent: US 5922320 (A) 1999-07-13 |
| 73 |
In vivo binding pair pretargeting with antibodies and methotrexate analogs Nicholas Pomato, Richard P. McCabe, Gregory A. Hawkins, Reinhard Bredehorst, Chong-Ho Kim, Carl-Wilhelm Vogel Patent: US 5965106 (A) 1999-10-12 |
1998 | |
| 72 |
Protease-derivatized cobra venom factor with retention of bioactivity Markus W. Ollert , Patrick Ziegelmüller, Thomas Grunwald, Reinhard Bredehorst, Carl-Wilhelm Vogel Patent: US 5714344 (A) 1998-02-03 |
1997 | |
| 71 |
Expression of a 260 kDa neuroblastoma surface antigen, the target of cytotoxic natural human IgM: correlation to MYCN amplification and effects of retinoic acid Kerstin A. David, A. Ehrhardt, Markus W. Ollert , Rudolf Erttmann, Reinhard Bredehorst, Carl-Wilhelm Vogel European Journal of Cancer 33, 1937-1941 (1997) |
| 70 |
Mechanisms of in vivo antineuroblastoma activity of human natural IgM Markus W. Ollert , Kerstin A. David, Caren Vollmert, Hartmut Juhl, Rudolf Erttmann, Reinhard Bredehorst, Carl-Wilhelm Vogel European Journal of Cancer 33, 1942-1948 (1997) |
| 69 |
Additive cytotoxicity of different monoclonal antibody-cobra venom factor conjugates for human neuroblastoma cells Hartmut Juhl, Eugene C. Petrella, Nai-Kong V. Cheung, Reinhard Bredehorst, Carl-Wilhelm Vogel Immunobiology 197, 444-459 (1997) |
| 68 |
Immunoconjugates Carl-Wilhelm Vogel, Reinhard Bredehorst -/- Editor: Renato Dulbecco Encyclopedia of Human Biology, 2nd Edition 4, 112.1-112.15 (1997), Publisher: Academic Press, San Diego |
1996 | |
| 67 |
Growth arrest of solid human neuroblastoma xenografts in nude rats by natural IgM from healthy humans Kerstin A. David, Markus W. Ollert , Hartmut Juhl, Caren Vollmert, Rudolf Erttmann, Carl-Wilhelm Vogel, Reinhard Bredehorst Nature Medicine 2, 686-689 (1996) |
| 66 |
Naturally occurring humoral cytotoxicity against neuroblastoma (NB) cells in healthy persons and NB patients Rudolf Erttmann, Caroline Schmitt, Markus W. Ollert , Kerstin A. David, Reinhard Bredehorst, Carl-Wilhelm Vogel Pediatric Hematology and Oncology 13, 545-548 (1996) |
| 65 |
Normal human serum contains a natural IgM antibody cytotoxic for human neuroblastoma cells Markus W. Ollert , Kerstin A. David, Caroline Schmitt, Alexander Hauenschild, Reinhard Bredehorst, Rudolf Erttmann, Carl-Wilhelm Vogel Proceedings of the National Academy of Sciences of the United States of America 93, 4498-4503 (1996) |
| 64 |
Structure and function of cobra venom factor, the complement-activating protein in cobra venom Carl-Wilhelm Vogel, Reinhard Bredehorst, David C. Fritzinger, Thomas Grunwald, Patrick Ziegelmüller, Michael A. Kock Advances in Experimental Medicine and Biology 391 (Natural Toxins 2) 97-114 (1996) |
| 63 |
In vivo binding pair pretargeting using targeting moiety-affinity component conjugate and affinity component binding partner-functional moiety conjugate Nicholas Pomato, Richard P. McCabe, Gregory A. Hawkins, Reinhard Bredehorst, Chong-Ho Kim, Carl-Wilhelm Vogel Patent: US 5578289 (A) 1996-11-26 |
1995 | |
| 62 |
Cobra venom factor immunoconjugates: effects of carbohydrate-directed versus amino group-directed conjugation Jane J. Zara, Nicholas Pomato, Richard P. McCabe, Reinhard Bredehorst, Carl-Wilhelm Vogel Bioconjugate Chemistry 6, 367-372 (1995) |
| 61 |
Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients Markus W. Ollert , Christine Wende, Martin Görlich, Candice G. McMullanvogel, Margarete Borg-Von Zepelin, Carl-Wilhelm Vogel, Hans Christian Korting Journal of Clinical Microbiology 33, 2543-2549 (1995) |
| 60 |
Classical complement pathway activation on nucleated cells. Role of factor H in the control of deposited C3b Markus W. Ollert , Kerstin A. David, Reinhard Bredehorst, Carl-Wilhelm Vogel Journal of Immunology 155, 4955-4962 (1995) |
| 59 |
Molecular cloning and derived primary structure of cobra venom factor David C. Fritzinger, Reinhard Bredehorst, Carl-Wilhelm Vogel Proceedings of the National Academy of Sciences of the United States of America 92, 7605-7605 (1995) |
| 58 |
Immunoconjugates in medicine (in Chinese) Reinhard Bredehorst, Carl-Wilhelm Vogel -/- Editor: Fuan Wang Internalization of Biological Macromolecules 223-236 (1995), Publisher: Science Press, Beijing |
| 57 |
Protease-derivatized cobra venom factor Markus W. Ollert , Patrick Ziegelmüller, Thomas Grunwald, Reinhard Bredehorst, Carl-Wilhelm Vogel Patent: WO 9507299 (A1) 1995-03-16 |
1994 | |
| 56 |
Immunoreactivity
and function of oligosaccharides in cobra venom factor D. Channe Gowda, Eugene C. Petrella, T. Tilak Raj, Reinhard Bredehorst, Carl-Wilhelm Vogel Journal of Immunology 152, 2977-2986 (1994) |
| 55 |
Antibody-mediated complement activation on nucleated cells Markus W. Ollert , Joseph V. Kadlec, Kerstin A. David, Eugene C. Petrella, Reinhard Bredehorst, Carl-Wilhelm Vogel Journal of Immunology 153, 2213-2221 (1994) |
| 54 |
Molecular cloning and derived primary structure of cobra venom factor David C. Fritzinger, Reinhard Bredehorst, Carl-Wilhelm Vogel Proceedings of the National Academy of Sciences of the United States of America 91, 12775-12779 (1994) |
| 53 |
Cobra venom factor, the complement-activating protein of cobra venom: Molecular cloning and derived primary structure David C. Fritzinger, Michael A. Kock, Thomas Grunwald, Patrick Ziegelmüller, B. Kunze, Markus W. Ollert , Reinhard Bredehorst, Carl-Wilhelm Vogel -/- Editor: Rainer Ansorge Hamburger Beiträge zur Wissenschaftsgeschichte 15, 565-591 (1994), ISBN 978-3-496-02540-5; 3-496-02540-9 , Publisher: Dietrich Reimer Verlag, Berlin - Hamburg Alternative Source Name: Schlaglichter der Forschung. Zum 75. Jahrestag der Universität Hamburg 1994 |
| 52 |
Molecular cloning of cDNA for cobra complement C3 and its analogs CVF1 and CVF2 David C. Fritzinger, Reinhard Bredehorst, Carl-Wilhelm Vogel Patent: WO 9423024 (A1) 1994-10-13 |
1993 | |
| 51 |
Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65 Markus W. Ollert , Joseph V. Kadlec, Eugene C. Petrella, Reinhard Bredehorst, Carl-Wilhelm Vogel Cancer Research 53, 592-599 (1993) |
| 50 |
Delivery of radionuclides to pretargeted monoclonal antibodies using dihydrofolate reductase and methotrexate in an affinity system Gregory A. Hawkins, Richard P. McCabe, Chong-Ho Kim, Ramaswamy Subramanian, Reinhard Bredehorst, Gregory A. McCullers, Carl-Wilhelm Vogel, Michael G. Hanna, Nicholas Pomato Cancer Research 53, 2368-2373 (1993) |
| 49 |
In vivo binding pair pretargeting for site-specific delivery of functional moiety in radioimaging or radiotherapy Nicholas Pomato, Richard P. McCabe, Gregory A. Hawkins, Reinhard Brederhorst, Chong-Ho Kim, Carl-Wilhelm Vogel Patent: WO 9317707 (A1) 1993-09-16 |
1992 | |
| 48 |
Primary structure of cobra complement component C3 David C. Fritzinger, Eugene C. Petrella, Mark B. Connelly, Reinhard Bredehorst, Carl-Wilhelm Vogel Journal of Immunology 149, 3554-3562 (1992) |
| 47 |
Structure of the major oligosaccharide of cobra venom factor D. Channe Gowda, Michael Schultz, Reinhard Bredehorst, Carl-Wilhelm Vogel Molecular Immunology 29, 335-342 (1992) |
| 46 |
Continuous flow immunoassay: use of a novel trifunctional carrier molecule for the synthesis of fluorophore-labeled antigens Reinhard Bredehorst, Gregory A. Wemhoff, Anne W. Kusterbeck, Paul T. Charles, Frances S. Ligler, Carl-Wilhelm Vogel GBF Monographs 17 (Fundamentals, Technologies and Applications) 453-460 (1992) |
1991 | |
| 45 |
Novel trifunctional carrier molecule for the fluorescent labeling of haptens Reinhard Bredehorst, Gregory A. Wemhoff, Anne W. Kusterbeck, Paul T. Charles, Richard B. Thompson, Frances S. Ligler, Carl-Wilhelm Vogel Analytical Biochemistry 193, 272-279 (1991) |
| 44 |
A carbohydrate-directed heterobifunctional cross-linking reagent for the synthesis of immunoconjugates Jane J. Zara, Richard D. Wood, Peter Boon, Chong-Ho Kim, Nicholas Pomato, Reinhard Bredehorst, Carl-Wilhelm Vogel Analytical Biochemistry 194, 156-162 (1991) |
| 43 |
Ligand-label conjugates which contain polyoxoanions of sulfur or phosphorus Reinhard Bredehorst, Frances S. Ligler, Anne W. Kusterbeck, Gregory A. Wemhoff, Carl-Wilhelm Vogel Patent: WO 9116344 (A1) 1991-10-31 |
1990 | |
| 42 |
A continuous flow immunoassay for rapid and sensitive detection of small molecules Anne W. Kusterbeck, Gregory A. Wemhoff, Paul T. Charles, Doyle A. Yeager, Reinhard Bredehorst, Carl-Wilhelm Vogel, Frances S. Ligler Journal of Immunological Methods 135, 191-197 (1990) |
| 41 |
C3-cleaving membrane proteinase. A new complement regulatory protein of human melanoma cells Markus W. Ollert , Raymond Frade, Anny Fiandino, Mounanandham Panneerselvam, Eugene C. Petrella, Monique Barel, Michael K. Pangburn, Reinhard Bredehorst, Carl-Wilhelm Vogel Journal of Immunology 144, 3862-3867 (1990) |
| 40 |
Complement killing of human neuroblastoma cells: a cytotoxic monoclonal antibody and its F(ab)'2-cobra venom factor conjugate are equally cytotoxic Hartmut Juhl, Eugene C. Petrella, Nai-Kong V. Cheung, Reinhard Bredehorst, Carl-Wilhelm Vogel Molecular Immunology 27, 957-964 (1990) |
| 39 |
Spezifische Elimination humaner Neuroblastomzellen durch die Anwendung von monoklonalen Antikörper-Cobra Venom Faktor Conjugaten: Ein Modell zur Tumor-Therapie (Specific elimination of human Neuroblastoma cells by monoclonal antibody-cobra venom factor conjugates: a tumor therapy model) Hartmut Juhl, Eugene C. Petrella, Nai-Kong V. Cheung, Reinhard Bredehorst, Carl-Wilhelm Vogel -/- Editors: Rudolf Häring, Konrad Meßmer, Edgar Ungeheuer Chirurgisches Forum '90 für experimentelle und klinische Forschung 289-295 (1990), ISBN 978-3-540-52392-5 , Publisher: Springer-Verlag, Berlin, Heidelberg Alternative Source Name: 107. Kongreß der Deutschen Gesellschaft für Chirurgie, Berlin, 17.-21. April 1990; Langenbecks Archiv fur Chirurgie vereinigt mit Bruns' Beiträge fur Klinische Chirurgie, Supplement 1990 |
| 38 |
The central role of cell surface-deposited C3b for the Complement susceptibility of human melanoma cells Reinhard Bredehorst, Carl-Wilhelm Vogel -/- Editor: Soldano Ferrone Human Melanoma. Immunology, Diagnostics and Therapy 133-150 (1990), Publisher: Springer-Verlag, Berlin, Heidelberg |
| 37 |
Site-specific in-vivo activation of prodrugs Reinhard Bredehorst, Chong-Ho Kim, Richard P. McCabe, Nicholas Pomato, Carl-Wilhelm Vogel Patent: WO 9007929 (A1) 1990-07-26 |
| 36 |
Preparation of site-specific heterobifunctional crosslinking reagents, their use, and kits containing them Jane J. Zara, Richard D. Wood, Reinhard Bredehorst, Carl-Wilhelm Vogel Patent: WO 9010621 (A1) 1990-09-20 |
1989 | |
| 35 |
The
oligosaccharide chains of cobra venom factor are required for complement activation Alice H. Grier, Carl-Wilhelm Vogel Molecular Immunology 26, 563-574 (1989) |
1988 | |
| 34 |
Differences in uptake of mycobacteria by human monocytes: a role for complement Rodney P. Swartz, David Naai, Carl-Wilhelm Vogel, Henry Yeager Infection and Immunity 56, 2223-2227 (1988) |
| 33 |
A novel cleavage product of human complement component C3 with structural and functional properties of cobra venom factor M. Clare O'Keefe, Lynn H. Caporale, Carl-Wilhelm Vogel Journal of Biological Chemistry 263, 12690-12697 (1988) |
| 32 |
Synthesis of antibody conjugates with cobra venom factor using heterobifunctional cross-linking reagents Carl-Wilhelm Vogel Targeted Diagnosis and Therapy 1, 191-224 (1988) |
| 31 |
Potential use of monoclonal antibody-drug conjugates to prevent drug resistance Carl-Wilhelm Vogel, Reinhard Bredehorst, Mounanandham Panneerselvam, Carole J. Spangler -/- Editor: P. V. Woolley, K. P. Tew Bristol-Myers Cancer Symposia 9 (Mechanisms of Drug Resistance in Neoplastic Cells) 371-383 (1988), Publisher: Academic Press, New York |
| 30 |
Detectably labeled cephalosporin assay for β-lactamase determination Reinhard Bredehorst, Abdolhossen Talebian, Charles F. Hammer, Carl-Wilhelm Vogel Patent: US 4764462 (A) 1988-08-16 |
1987 | |
| 29 |
A homogeneous immunoassay for the mycotoxin T-2 utilizing liposomes, monoclonal antibodies, and complement Frances S. Ligler, Reinhard Bredehorst, Abdolhossen Talebian, Lisa C. Shriver, Charles F. Hammer, James P. Sheridan, Carl-Wilhelm Vogel, Bruce P. Gaber Analytical Biochemistry 163, 369-375 (1987) |
| 28 |
Resistance of human melanoma cells against the cytotoxic and complement-enhancing activities of doxorubicin Mounanandham Panneerselvam, Reinhard Bredehorst, Carl-Wilhelm Vogel Cancer Research 47, 4601-4607 (1987) |
| 27 |
Immune and nonimmune effector functions of IgG3 mouse monoclonal antibody R24 detecting the disialoganglioside GD3 on the surface of melanoma cells Sydney Welt, Elizabeth A. Carswell, Carl-Wilhelm Vogel, Herbert F. Oettgen, Lloyd J. Old Clinical Immunology and Immunopathology 45, 214-229 (1987) |
| 26 |
Doxorubicin enhances complement susceptibility of human melanoma cells by extracellular oxygen radical formation Reinhard Bredehorst, Mounanandham Panneerselvam, Carl-Wilhelm Vogel Journal of Biological Chemistry 262, 2034-2041 (1987) |
| 25 |
Antibody conjugates with cobra venom factor. Synthesis and biochemical characterization Eugene C. Petrella, Scott D. Wilkie, Craig A. Smith, Alton C. Morgan, Carl-Wilhelm Vogel Journal of Immunological Methods 104, 159-172 (1987) |
| 24 |
Cobra venom factor and human C3 share carbohydrate antigenic determinants Alice H. Grier, Michael Schultz, Carl-Wilhelm Vogel Journal of Immunology 139, 1245-1252 (1987) |
| 23 |
Immunoconjugates: Antibody Conjugates in Radioimaging and Therapy of Cancer Editor: Carl-Wilhelm Vogel 384 pp (1987), Publisher: Oxford University Press, New York |
1986 | |
| 22 |
Effects of a complex combining an alternative-pathway complement activator with a nonactivating anti-Entamoeba histolytica monoclonal antibody Carl-Wilhelm Vogel, Ricardo Alaniz, Ruth Capin, Librado Ortiz-Ortiz Archivos de Investigacion Medica 17, 269-271 (1986) |
| 21 |
Effect of covalent attachment of immunoglobulin fragments on liposomal integrity Reinhard Bredehorst, Frances S. Ligler, Anne W. Kusterbeck, Eddie L. Chang, Bruce P. Gaber, Carl-Wilhelm Vogel Biochemistry 25, 5693-5698 (1986) |
| 20 |
The effect of complement depletion on immunologically mediated middle ear effusion and inflammation A. F. Ryan, A. Catanzaro, S. I. Wasserman, J. P. Harris, Carl-Wilhelm Vogel Clinical Immunology and Immunopathology 40, 410-421 (1986) |
| 19 |
The effects of metal ions and temperature on the interaction of cobra venom factor and human complement factor B Preston Hensley, M. Clare O'Keefe, Carole J. Spangler, James C. Osborne, Carl-Wilhelm Vogel Journal of Biological Chemistry 261, 11038-11044 (1986) |
| 18 |
A molecular mechanism of complement resistance of human melanoma cells Mounanandham Panneerselvam, Sydney Welt, Lloyd J. Old, Carl-Wilhelm Vogel Journal of Immunology 136, 2534-2541 (1986) |
| 17 |
Immobilized doxorubicin increases the complement susceptibility of human melanoma cells by protecting complement component C3b against inactivation Mounanandham Panneerselvam, Reinhard Bredehorst, Carl-Wilhelm Vogel Proceedings of the National Academy of Sciences of the United States of America 83, 9144-9148 (1986) |
1985 | |
| 16 |
The cobra complement system: I. The alternative pathway of activation Carl-Wilhelm Vogel, Hans J. Müller-Eberhard Developmental & Comparative Immunology 9, 311-325 (1985) |
| 15 |
The cobra complement system: II. The membrane attack complex Carl-Wilhelm Vogel, Hans J. Müller-Eberhard Developmental & Comparative Immunology 9, 327-333 (1985) |
| 14 |
Untersuchungen zur Strukturhomologie von Kobrafaktor mit dem menschlichen Komplementprotein C3 sowie Synthese kovalenter Hybridproteine aus Kobrafaktor und monoklonalen Antikörpern als selektiv-zytotoxisches Prinzip Carl-Wilhelm Vogel -/- Supervisors: Günther Gercken Dissertation, Hamburg (1985) |
| 13 |
In vivo studies with covalent conjugates of cobra venom factor and monoclonal antibodies to human tumors Carl-Wilhelm Vogel, Scott D. Wilkie, Alton C. Morgan -/- Editor: Rolf Neth Haematology and Blood Transfusion 29 (Modern trends in human leukemia VI : new results in clinical and biological research including pediatric oncology ; Wilsede Joint Meeting on Pediatric Oncology 3, Hamburg , June 21/22, 1984 ) 514-517 (1985) |
1984 | |
| 12 |
Molecular architecture of human properdin, a positive regulator of the alternative pathway of complement Craig A. Smith, Michael K. Pangburn, Carl-Wilhelm Vogel, Hans J. Müller-Eberhard Journal of Biological Chemistry 259, 4582-4588 (1984) |
| 11 |
MHC class III products: an electron microscopic study of the C3 convertases of human complement Craig A. Smith, Carl-Wilhelm Vogel, Hans J. Müller-Eberhard Journal of Experimental Medicine 159, 324-329 (1984) |
| 10 |
Cobra venom factor: improved method for purification and biochemical characterization Carl-Wilhelm Vogel, Hans J. Müller-Eberhard Journal of Immunological Methods 73, 203-220 (1984) |
| 9 |
Cobra venom factor: structural homology with the third component of human complement Carl-Wilhelm Vogel, Craig A. Smith, Hans J. Müller-Eberhard Journal of Immunology 133, 3235-3241 (1984) |
1983 | |
| 8 |
The
membrane attack complex of complement and its precursor proteins lack phospholipase activity Carl-Wilhelm Vogel, Andreas Plückthun, Eckhard R. Podack, Edward A. Dennis, Hans J. Müller-Eberhard Molecular Immunology 20, 377-382 (1983) |
1982 | |
| 7 |
The cobra venom factor-dependent C3 convertase of human complement. A kinetic and thermodynamic analysis of a protease acting on its natural high molecular weight substrate Carl-Wilhelm Vogel, Hans J. Müller-Eberhard Journal of Biological Chemistry 257, 8292-8299 (1982) |
| 6 |
Ultrastructure of cobra venom factor-dependent C3/C5 convertase and its zymogen, factor B of human complement Craig A. Smith, Carl-Wilhelm Vogel, Hans J. Müller-Eberhard Journal of Biological Chemistry 257, 9879-9882 (1982) |
1981 | |
| 5 |
Hemolytic assay for venom phospholipase A2 Carl-Wilhelm Vogel, Andreas Plückthun, Hans J. Müller-Eberhard, Edward A. Dennis Analytical Biochemistry 118, 262-268 (1981) |
| 4 |
Induction of immune cytolysis: Tumor-cell killing by complement is initiated by covalent complex of monoclonal antibody and stable C3/C5 convertase Carl-Wilhelm Vogel, Hans J. Müller-Eberhard Proceedings of the National Academy of Sciences of the United States of America 78, 7707-7711 (1981) |
1979 | |
| 3 |
A new cAMP affinity matrix for the rapid purification of protein kinase regulatory subunits Wolfgang Weber, Carl-Wilhelm Vogel, Helmuth Hilz FEBS Letters 99, 62-66 (1979) |
1976 | |
| 2 |
Verbesserung der fluoreszenzspektralphotometrischen Methode und Entwicklung einer spektraldensitometrischen Methode zur Bestimmung von Chloroquin in biologischen Flüssigkeiten Carl-Wilhelm Vogel -/- Supervisors: Eberhard Königk Dissertation (med), Hamburg (1976) |
1975 | |
| 1 |
Spectrofluorometric and Spectrodensitometric Determination of Chloroquine in Plasma and Urine Carl-Wilhelm Vogel, Eberhard Königk Tropenmedizin und Parasitologie 26, 278-280 (1975) |